EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms

Detao Meng, Zhaohui Jin, Yixuan Wang, Boyan Fang iD

CNS Neuroscience & Therapeutics · 2023-08 · 29 (8) · 2259-2266

DOI: 10.1111/cns.14173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 16.03.2023. Verfasst von Detao Meng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Cognitive Dysfunction, Apathy, Psychotic Disorders. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In this study, we aimed to investigate the effect of neuropsychiatric symptoms (NPS) on the rate of cognitive decline for both global cognition and specific cognitive domains in a cohort of patients from the Parkinson's Progression Markers Initiative (PPMI).

Method

Prospectively longitudinal data were obtained from the PPMI cohort. NPS, including depression, anxiety, apathy, psychosis, impulse control disorders (ICDs), and cognition ability, were evaluated by a series of questionnaires. Linear mixed‐effects models were used to investigate the relationship between NPS and the rate of cognitive decline. Generalized estimating equations (GEEs) were used to investigate the relationship between NPS and the occurrence of mild cognitive impairment (MCI).

Results

In total, 423 patients with Parkinson's disease (PD) were recruited at baseline and 395, 378, 366, 346, and 315 participants were followed up at 1, 2, 3, 4, and 5 years, respectively. Depression, anxiety, apathy, and psychosis were associated with global cognitive decline. Except for those with ICDs, patients with psychosis, depression, anxiety, and apathy were more likely to meet the criteria for MCI. Patients with depression and anxiety showed a progressive decline in four major cognitive domains. Apathy and ICDs were separately associated with a progressive decline in processing speed‐attention and memory, respectively.

Conclusions

Neuropsychiatric symptoms, including psychosis, depression, anxiety, and apathy, could be used to predict future cognitive decline in patients with PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseCognitive DysfunctionApathyPsychotic DisordersHumansCognitionNeuropsychological Tests

Stichwörter der Autor:innen

Parkinson's diseasecognitive impairmentneuropsychiatric symptomsprediction

Autor:innen und Institutionen

  • Parkinson Medical Center, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Boyan Fang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Meng, D., Jin, Z., Wang, Y., & Fang, B. (2023). Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms. CNS Neuroscience & Therapeutics, 29(8), 2259-2266. https://doi.org/10.1111/cns.14173

Vancouver

Meng D, Jin Z, Wang Y, Fang B. Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms. CNS Neuroscience & Therapeutics. 2023;29(8):2259-2266. doi:10.1111/cns.14173

BibTeX
@article{Meng2023,
  author = {Meng, Detao and Jin, Zhaohui and Wang, Yixuan and Fang, Boyan},
  title = {Longitudinal cognitive changes in patients with early Parkinson's disease and neuropsychiatric symptoms},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2023},
  volume = {29},
  number = {8},
  pages = {2259--2266},
  doi = {10.1111/cns.14173}
}
Kostenlos starten →